 |
 |

Neuro-oncology 1999
Arch Neurol. 1999;56:397-398.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
MALIGNANT BRAIN tumors occur in more than 40,000 individuals in the United States each year. About half are primary and the remainder are metastatic. Brain metastasis is frequent in patients due to several systemic malignancies including lung, breast, melanoma, lymphoma, and colon cancers. Brain tumors are the second most common cause of cancer-related death in people up to the age of 35 years. Present treatment modalities include surgery, radiation, and chemotherapy. Despite these therapeutic approaches studied comprehensively with numerous combined modality treatment trials during the past 20 years, patient survival is still numbered in months.1
The neurologic complications of systemic cancer are not uncommon. Cancer-related pain is most commonly caused by a neurologic diagnosis, including tumor infiltration of nerves or plexus, spinal cord compression, radiculopathies, and meningeal or parenchymal spread.2
In this issue of the ARCHIVES, 9 major articles covering the important areas in neuro-oncology are presented that provide us . . . [Full Text of this Article]
|